AbbVie Financials
| ABBV34 Stock | BRL 69.32 2.53 3.79% |
AbbVie |
Understanding current and past AbbVie Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AbbVie's financial statements are interrelated, with each one affecting the others. For example, an increase in AbbVie's assets may result in an increase in income on the income statement.
Please note, the presentation of AbbVie's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AbbVie's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of AbbVie's management manipulating its earnings.
AbbVie Stock Summary
AbbVie competes with Hospital Mater, GP Investments, Metalrgica Riosulense, Extra Space, and CVS Health. AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. ABBVIE DRN operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 30000 people.| Instrument | Brazil Stock View All |
| Exchange | Sao Paulo Exchange |
| Business Address | 1 North Waukegan |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Major |
| Benchmark | Dow Jones Industrial |
| Website | www.abbvie.com |
| Phone | 847 932 7900 |
| Currency | BRL - Brazilian Real |
You should never invest in AbbVie without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of AbbVie Stock, because this is throwing your money away. Analyzing the key information contained in AbbVie's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
AbbVie Key Financial Ratios
AbbVie's financial ratios allow both analysts and investors to convert raw data from AbbVie's financial statements into concise, actionable information that can be used to evaluate the performance of AbbVie over time and compare it to other companies across industries.| Return On Equity | 0.75 | |||
| Return On Asset | 0.0927 | |||
| Number Of Employees | 26 | |||
| Beta | 0.58 | |||
| Z Score | 22.2 |
AbbVie Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AbbVie's current stock value. Our valuation model uses many indicators to compare AbbVie value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AbbVie competition to find correlations between indicators driving AbbVie's intrinsic value. More Info.AbbVie Inc is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.12 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for AbbVie Inc is roughly 8.12 . Comparative valuation analysis is a catch-all model that can be used if you cannot value AbbVie by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AbbVie's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.AbbVie Inc Systematic Risk
AbbVie's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AbbVie volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on AbbVie Inc correlated with the market. If Beta is less than 0 AbbVie generally moves in the opposite direction as compared to the market. If AbbVie Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AbbVie Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AbbVie is generally in the same direction as the market. If Beta > 1 AbbVie moves generally in the same direction as, but more than the movement of the benchmark.
AbbVie December 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of AbbVie help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AbbVie Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of AbbVie Inc based on widely used predictive technical indicators. In general, we focus on analyzing AbbVie Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AbbVie's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.67 | |||
| Information Ratio | 0.0402 | |||
| Maximum Drawdown | 15.14 | |||
| Value At Risk | (4.40) | |||
| Potential Upside | 3.67 |
Complementary Tools for AbbVie Stock analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |